Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How much do we gain by reducing time to reperfusion therapy?

R M Califf1, L K Newby

  • 1Duke Clinical Research Institute, Durham, North Carolina 27705, USA.

The American Journal of Cardiology
|December 19, 1996
PubMed
Summary

Rapid treatment for myocardial infarction (MI) significantly reduces adverse outcomes. While reducing patient presentation time is challenging, optimizing emergency department protocols can shorten treatment delays.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America.

American heart journal·2024
Same author

Metabolome-based signature of disease pathology in MS.

Multiple sclerosis and related disorders·2019
Same author

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy.

Indian heart journal·2016
Same author

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.

Heart (British Cardiac Society)·2008
Same author

Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns.

Heart (British Cardiac Society)·2005
Same author

Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes.

Journal of medical genetics·2004

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Minimizing time from myocardial infarction (MI) symptom onset to thrombolytic therapy is crucial.
  • Large trials show a direct correlation between faster treatment and reduced adverse clinical outcomes.
  • The benefit of treatment within the first hour of MI symptom onset requires further investigation.

Purpose of the Study:

  • To review factors influencing delays in MI treatment.
  • To explore strategies for reducing pre-hospital and in-hospital delays.
  • To assess the impact of emergency department interventions on treatment times.

Main Methods:

  • Literature review of large-scale trials on MI treatment delays.
  • Analysis of factors affecting patient presentation and treatment initiation.

Related Experiment Videos

  • Evaluation of proposed interventions for streamlining emergency care.

    • Main Results:

    • Patient characteristics influence presentation delays and mortality risk.
    • Public education campaigns have had limited success in reducing presentation times.
    • Treatment delays, though smaller than presentation delays, are reducible through field ECG transmission and streamlined ED protocols.

    Conclusions:

    • Reducing time-to-treatment for MI is essential for improving patient outcomes.
    • While patient-side delays are difficult to shorten, optimizing emergency department workflows offers a promising avenue.
    • Implementing strategies like field ECGs and rapid ED protocols can significantly decrease treatment delays.